Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease

Clinical trial NCT06579703 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06579703
Sponsor: Children's Blood and Cancer Center at Dell Children's Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Crisis Veno-occlusive Disease

Start date: 2024-09-30
Primary completion: 2027-07-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.